Cargando…
Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
BACKGROUND/AIM: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080371/ https://www.ncbi.nlm.nih.gov/pubmed/31905492 http://dx.doi.org/10.3906/sag-1908-182 |
_version_ | 1783508008008941568 |
---|---|
author | DOGAN, İsmail KALYONCU, Umut KILIÇ, Levent AKDOĞAN, Ali KARADAĞ, Ömer KİRAZ, Sedat A. BİLGEN, Şule ERTENLİ, İhsan |
author_facet | DOGAN, İsmail KALYONCU, Umut KILIÇ, Levent AKDOĞAN, Ali KARADAĞ, Ömer KİRAZ, Sedat A. BİLGEN, Şule ERTENLİ, İhsan |
author_sort | DOGAN, İsmail |
collection | PubMed |
description | BACKGROUND/AIM: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. MATERIALS AND METHODS: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology (ACR) revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. RESULTS: AVN was found in 11 of 127 (8.7%) SLE patients. Hyperlipidemia (P < 0.001), cushingoid body habitus (P < 0.001), and proteinuria (P = 0.013) were found at higher rates in the AVN group. All of the 11 AVN cases had osteoporosis (P < 0.02). In multivariate regression analysis, daily steroid usage was the only factor for development of AVN in SLE. CONCLUSION: The hypothesis of our study was that an alternate day steroid regimen may decrease AVN frequency in SLE patients. |
format | Online Article Text |
id | pubmed-7080371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Scientific and Technological Research Council of Turkey |
record_format | MEDLINE/PubMed |
spelling | pubmed-70803712020-03-23 Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid DOGAN, İsmail KALYONCU, Umut KILIÇ, Levent AKDOĞAN, Ali KARADAĞ, Ömer KİRAZ, Sedat A. BİLGEN, Şule ERTENLİ, İhsan Turk J Med Sci Article BACKGROUND/AIM: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. MATERIALS AND METHODS: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology (ACR) revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. RESULTS: AVN was found in 11 of 127 (8.7%) SLE patients. Hyperlipidemia (P < 0.001), cushingoid body habitus (P < 0.001), and proteinuria (P = 0.013) were found at higher rates in the AVN group. All of the 11 AVN cases had osteoporosis (P < 0.02). In multivariate regression analysis, daily steroid usage was the only factor for development of AVN in SLE. CONCLUSION: The hypothesis of our study was that an alternate day steroid regimen may decrease AVN frequency in SLE patients. The Scientific and Technological Research Council of Turkey 2020-02-13 /pmc/articles/PMC7080371/ /pubmed/31905492 http://dx.doi.org/10.3906/sag-1908-182 Text en Copyright © 2019 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Article DOGAN, İsmail KALYONCU, Umut KILIÇ, Levent AKDOĞAN, Ali KARADAĞ, Ömer KİRAZ, Sedat A. BİLGEN, Şule ERTENLİ, İhsan Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
title | Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
title_full | Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
title_fullStr | Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
title_full_unstemmed | Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
title_short | Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
title_sort | avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080371/ https://www.ncbi.nlm.nih.gov/pubmed/31905492 http://dx.doi.org/10.3906/sag-1908-182 |
work_keys_str_mv | AT doganismail avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid AT kalyoncuumut avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid AT kiliclevent avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid AT akdoganali avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid AT karadagomer avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid AT kirazsedat avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid AT abilgensule avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid AT ertenliihsan avascularnecrosislessfrequentlyfoundinsystemiclupuserythematosuspatientswiththeuseofalternatedaycorticosteroid |